Cationic liposome-mediated efficient induction of type I interferons by a low dose of poly I:poly C in mouse cell lines

Journal of Biochemistry

Volumn 124, Issue 4, 1998, Pages 697-701

  Okamoto, Sachiko ^a,b   Watanabe, Yoshihiko ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TAKARA SHUZO CO LTD   (Japan)

Author keywords

Cationic liposomes; Efficient IFN induction; FITC poly I:poly C; Interferon; Poly I:poly C

Indexed keywords

CATION; INTERFERON; LIPOFECT ACE; LIPOFECTAMINE; LIPOFECTIN; LIPOSOME; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; FIBROBLAST CULTURE; MOUSE; NONHUMAN; PROTEIN INDUCTION;

ANIMALIA;

EID: 0031770407     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022168     Document Type: Article

References (36)

1. DeMaeyer, E. and DeMaeyer-Guignard, J. (1988) Interferons and Other Regulatory Cytokines, p. 448, John Wiley, New York
2. Gresser, I. and Tovey, M.G. (1978) Antitumor effects of interferon. Biochim. Biophys. Acta 516, 231-247
3. Watanabe, Y. (1994) Tumorigenicity and immunogenicity of IFN-γ producing tumor cells in Cytokine-Induced Tumor Immunogenicity (Forni, G., Foa, R., Santoni, A., and Frati, L., eds.) pp. 233-247, Academic Press, London
4. Abdel-Wahab, Z., Dar, M., Osanto, S., Fong, T., Vervaert, C.E., Hester, D., Jolly, D., and Seigler, H.F. (1997) Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon. Cancer Gene Ther. 4, 33-41
5. Colby, C. and Morgan, M.J. (1971) Interferon induction and action. Annu. Rev. Microbiol. 25, 333-360
6. Kleinschmidt, W.J. (1972) Biochemistry of interferon and its inducers. Annu. Rev. Biochem. 41, 517-542
7. Kelley, K.A. and Pitha, P.M. (1985) Differential effect poly rI· rC and Newcastle disease virus on the expression of interferon and cellular genes in mouse cells. Virology 147, 382-393
8. Stewart, II, W.E., Gosser, L.B., and Lockart, R.Z., Jr. (1971) Priming: a nonantiviral function of interferon. J. Virol. 7, 792-801
9. Dron, M., Lacasa, M., and Tovey, M.G. (1990) Priming affects the activity of a specific region of the promoter of the human beta interferon gene. Mol. Cell. Biol. 10, 854-858
10. Rodgers, R. and Merigan, T.C. (1972) Interferon and its inducers: antiviral and other effects. Crit. Rev. Clin. Lab. Sci. 3, 131-162
11. Carter, W.A. and DeClercq, E. (1974) Viral infection and host defense. Science 186, 1172-1178
12. Harary, R., Gonsky, R., Itamar, D., and Kaempfer, R. (1990) Relief of cytotoxicity and enhancement of interferon inducer activity of double-stranded RNA by eukaryotic initiation factor 2. Virology 174, 494-503
13. Stewart, II, W.E., DeClercq, E., Billiau, A., Desmyter, J., and DeSomer, P. (1972) Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic·polyribocytidylic acid. Proc. Nat. Acad. Sci. USA 7, 1851-1854
14. n complex for induction of human interferon. J. Mol. Biol. 70, 567-587
15. Ts'o, P.O.P., Alderfer, J.L., and Levy, J. (1976) An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid-polycytidylic acid and its mismatched analogues. Mol. Pharmacol. 12, 299-312
16. Hubbell, H.R. (1986) Synergistic antiproliferative effect of human interferons in combination with mismatched double-stranded RNA on human tumor cells. Int. J. Cancer 37, 359-365
17. Mayhew, E. and Papahadjopuolos, D. (1977) Cellular uptake and protection against virus infection by polyinosinic-polycytidilic acid entrapped within phospholipid vesicles. Mol. Pharmacol. 13, 488-495
18. Straub, S.X., Garry, R.F., and Magee, W.E. (1974) Interferon induction by poly(I):poly(C) enclosed in phospholipid particles. Infect. Immun. 10, 783-792
19. Magee, W.E. (1978) Potentiation of interferon production and stimulation of lympocytes by polyribonucleotides entrapped in liposomes. Ann. N.Y. Acad. Sci. 308, 308-324
20. Milhaud, P.G., Compagnon, B., Bienvenüe, A., and Philippot, J.R. (1992) Interferon production of L929 and HeLa cells enhanced by polyriboinosinic acid-polyribocytidylic acid pH-sensitive liposomes. Bioconjugate Chem. 3, 402-407
21. Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., and Danielsen, M. (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413 7417
22. Yuspa, S.H., Hawley-Nelson, P., Koehler, B., and Stanley, J.R. (1980) A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res. 40, 4694-4703
23. Maruguchi, Y., Toda, K.I., Fujii, K., Imamura, S., and Watanabe, Y. (1991) Survival period of tumor-bearing mice is prolonged after the interferon-γ-producing gene transfer. Cancer Lett. 60, 41-49
24. Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280-285
25. Watanabe, Y. and Kawade, Y. (1987) Induction, production and purification of natural mouse IFN-α and IFN-β in Lymphokines and Interferons: a Practical Approach (Clemens, M.J., Morris, A.G., and Gearing, J. eds.) pp. 1-14, IRL, Oxford
26. Watanabe, Y., Kuribayashi, K., Miyatake, S., Nishihara, K., Nakayama, E., Taniyama, T., and Sakata, T. (1989) Exogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C 1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc. Natl. Acad. Sci. USA 86, 9456-9760
27. Kawade, Y. and Watanabe, Y. (1987) Characterization of rat monoclonal antibodies to mouse interferon-α and -β in The Biology of the Interferon System 1986 (Cantell, K. and Schellekens, H., eds.) pp. 197-201, Martinus Nijhoff, Dordrecht
28. Mosmann, T. (1983) Rapid calorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63
29. Watanabe, Y. and Sakata, T. (1988) Highly efficient action of autocrine mouse interferon-γ expressed via a retroviral vector. Eur. J. Immunol. 18, 1627-1630
30. Kawabata, K., Kondo, M., Watanabe, Y., Takakura, Y., and Hashida, M. (1997) Non-polarized secretion of mouse interferon-β from gene-transferred human intestinal Caco-2 cells. Pharm. Res. 14, 483-485
31. Minty, A.J., Alonso, S., Guenet, J.L., and Buckingham, M.E. (1983) Number and organization of actin related sequences in the mouse genome. J. Mol. Biol. 167, 77-101
32. Ledley, F.D. (1995) Non viral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6, 1129-1144
33. Gao, X. and Huang, L. (1995) Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722
34. Droller, M. J. and Gomolka, D. (1982) Inhibition of tumor growth in association with modification of in vivo immune response by indomethacin and polyinosinic:polycytidylic acid. Cancer Res. 42, 5038-5045
35. Hubbell, H.R., Kvalnes-Krick, K., Carter, W.A., and Strayer, D.R. (1985) Antiproliferative and immunomodulatory actions of β-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice. Cancer Res. 45, 2481-2486
36. Carter, W.A. and DeClercq, E. (1974) Viral infection and host defense. Science 186, 1172-1178